Citadel Advisors’s TuHURA Biosciences HURA Stock Holding History

Citadel Advisors’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$544K	Buy	+232,319	New	+$541K	﹤0.01%	9653
2022 Q1	–	Sell	-142	Closed	-$127K	–	14758
2021 Q4	$127K	Buy	+142	New	+$192K	﹤0.01%	12471
2021 Q3	–	Sell	-26	Closed	-$104K	–	14814
2021 Q2	$104K	Sell	26 -18	-41%	-$51.7K	﹤0.01%	12891
2021 Q1	$134K	Buy	+44	New	+$149K	﹤0.01%	12178
2020 Q3	–	Sell	-13	Closed	-$16K	–	10864
2020 Q2	$16K	Buy	+13	New	+$16.6K	﹤0.01%	9586
2019 Q4	–	Sell	-19	Closed	-$18K	–	9883
2019 Q3	$18K	Buy	+19	New	+$35.7K	﹤0.01%	8966
2019 Q2	–	Sell	-3	Closed	-$22K	–	9976
2019 Q1	$22K	Hold	3	–	–	﹤0.01%	9049
2018 Q4	$21K	Buy	3 +1	+50%	+$9.7K	﹤0.01%	8738
2018 Q3	$20K	Buy	2 +1	+100%	+$10.8K	﹤0.01%	9010
2018 Q2	$15K	Hold	1	–	–	﹤0.01%	8693
2018 Q1	$14K	Buy	+1	New	+$21.9K	﹤0.01%	8159

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Citadel Advisors's HURA Position: Q2 2026 in Review

Citadel Advisors opened a new position in TuHURA Biosciences (HURA) in Q2 2026: 232,319 shares worth $544K. The stake represents ﹤0.01% of the portfolio and ranks #9653 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in HURA as recently as Q4 2021.

Citadel Advisors first reported a position in HURA in Q1 2018 and has held it in 11 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Citadel Advisors held 232,319 shares of TuHURA Biosciences worth $544K as of Q2 2026.
TuHURA Biosciences was a new Citadel Advisors position in Q2 2026.
TuHURA Biosciences made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9653 holding.
Citadel Advisors first reported a position in TuHURA Biosciences in Q1 2018 and has held it in 11 quarters since.
89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.